Skip to content
Trial Eligibility
Menu

Lung Cancer Clinical Trials near Palo Alto, CA

86 studies for Lung Cancer are recruiting at 266 sites within 50 miles of Palo Alto, California, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lung Cancer trials in the US or all trials near Palo Alto.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lung Cancer studies enrolling near Palo Alto

Showing the 50 nearest of 86 studies.
  1. Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

    NCT03851445

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Palo Alto Medical Foundation Health Care (Palo Alto, CA); Stanford Cancer Institute Palo Alto (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    33 sites within 50 mi
  2. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    NCT04267848

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Palo Alto Medical Foundation Health Care (Palo Alto, CA); Stanford Cancer Institute Palo Alto (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    23 sites within 50 mi
  3. Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

    NCT04181060

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Stanford Cancer Institute Palo Alto (Palo Alto, CA); Kaiser Permanente-Fremont (Fremont, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    15 sites within 50 mi
  4. Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

    NCT06616584

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: VA Palo Alto Health Care System (Palo Alto, CA); Kaiser Permanente Medical Center - Santa Clara (Santa Clara, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    12 sites within 50 mi
  5. Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

    NCT06031688

    • Phase 2
    • Ages 18 Minutes and older
    • Sex: All

    Nearest sites: Palo Alto Medical Foundation Health Care (Palo Alto, CA); Palo Alto Medical Foundation-Sunnyvale (Sunnyvale, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    10 sites within 50 mi
  6. Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

    NCT05624996

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Palo Alto Medical Foundation Health Care (Palo Alto, CA); Palo Alto Medical Foundation-Camino Division (Mountain View, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  7. Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

    NCT06116682

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Palo Alto Medical Foundation Health Care (Palo Alto, CA); Palo Alto Medical Foundation-Sunnyvale (Sunnyvale, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  8. A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

    NCT06793215

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Palo Alto Medical Foundation Research Center (Palo Alto, CA); California Pacific Medical Center (San Francisco, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  9. Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer

    NCT06080061

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Stanford University (Palo Alto, CA); Stanford Cancer Center South Bay (San Jose, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  10. Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

    NCT06890598

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Stanford Cancer Center (Palo Alto, CA); BASS Cancer Center (Walnut Creek, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  11. Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

    NCT07393555

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Palo Alto Medical Foundation Health Care (Palo Alto, CA); Alta Bates Summit Medical Center-Herrick Campus (Berkeley, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  12. Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery

    NCT03582124

    • Phase 1/2
    • Ages 19 years and older
    • Sex: All

    Nearest site: Stanford University, School of Medicine (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

    NCT04300556

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford Women's Cancer Center (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

    NCT04981119

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford University (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

    NCT06179160

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford University (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

    NCT06562192

    • Phase 1
    • Ages 18 to 100 years
    • Sex: All

    Nearest site: Stanford University Medical Center (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

    NCT06681220

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: VA Palo Alto Health Care System, Palo Alto, CA (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

    NCT07168993

    • Interventional
    • Ages 50 to 80 years
    • Sex: All

    Nearest site: VA Palo Alto Health Care System (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Engagement of Veterans With Lung Cancer

    NCT07219251

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: Veterans Affairs Palo Alto Health Care System (VAPAHCS) (Palo Alto, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

    NCT07489066

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Stanford Cancer Institute (Stanford, CA); Stanford Hospital Investigational Drug Services (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  21. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest sites: Massive Bio SYNERGY-AI site (Stanford, CA); Massive Bio SYNERGY-AI site (San Francisco, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  22. Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

    NCT06162221

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Stanford University - Stanford Cancer Institute (Stanford, CA); UCSF Medical Center - Mission Bay (San Francisco, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  23. Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

    NCT00568490

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford University School of Medicine (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

    NCT04119024

    • Phase 1
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Stanford Cancer Institute (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

    NCT04282044

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford University (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLC

    NCT04585490

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford University (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies

    NCT05443126

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford University (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

    NCT05498428

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford Cancer Institute (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements

    NCT05987644

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford University (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

    NCT06051695

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford University (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. Safety and Efficacy of OBX-115 in Advanced Solid Tumors

    NCT06060613

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford Cancer Institute (Melanoma/NSCLC) (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

    NCT06128551

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford Cancer Institute (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

    NCT06196008

    • Interventional
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Standard University (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

    NCT06706076

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford University Medical Center (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. A Study of LY4175408 in Participants With Advanced Cancer

    NCT07046923

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford Medicine Cancer Center (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

    NCT07111520

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stanford Cancer Institute (Stanford, CA)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    NCT06418204

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente- Marshall Medical Offices (Redwood City, CA); Kaiser Permanente-Fremont (Fremont, CA)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    16 sites within 50 mi
  38. ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

    NCT05059444

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Redwood City (Redwood City, CA)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

    NCT05642572

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Palo Alto Medical Foundation-Sunnyvale (Sunnyvale, CA); Palo Alto Medical Foundation-Fremont (Fremont, CA)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    17 sites within 50 mi
  40. Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

    NCT06767514

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Clinical Study Site (Sunnyvale, CA); Clinical Study Site (Alameda, CA)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  41. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

    NCT06498635

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente-Fremont (Fremont, CA); Kaiser Permanente Medical Center - Santa Clara (Santa Clara, CA)

    Distance to nearest recruiting site
    ~11 mi (city-level)
    Recruiting sites
    11 sites within 50 mi
  42. Distance-Based Exercise to Preserve Function and Prevent Disability

    NCT07059884

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente-Fremont (Fremont, CA); Kaiser Permanente Medical Center - Santa Clara (Santa Clara, CA)

    Distance to nearest recruiting site
    ~11 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  43. A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    NCT06667076

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente Santa Clara Medical Center (Santa Clara, CA); UCSF Zuckerberg San Francisco General Hospital (San Francisco, CA)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  44. Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

    NCT05297734

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Santa Clara Valley Medical Center (Fruitdale, CA); Kaiser Foundation Research Institute (San Francisco, CA)

    Distance to nearest recruiting site
    ~15 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  45. The Vanguard Study: Testing a New Way to Screen for Cancer

    NCT06995898

    • Interventional
    • Ages 45 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Kaiser Permanente-Division of Research (Pleasanton, CA)

    Distance to nearest recruiting site
    ~21 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. Understanding New Cachexia Subtypes Through Observational Epidemiological Research

    NCT07776353

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Kaiser Permanente Northern California (Pleasanton, CA)

    Distance to nearest recruiting site
    ~21 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

    NCT07473128

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Pharmacosmos Investigational Site (Oakland, CA)

    Distance to nearest recruiting site
    ~26 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. Biomarkers for Risk Stratification in Lung Cancer

    NCT03774758

    • Observational
    • Ages 40 years and older
    • Sex: All

    Nearest sites: San Francisco VA Medical Center (San Francisco, CA); University of California, San Francisco (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  49. Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

    NCT04613596

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: San Francisco Veterans Affairs Medical Center (San Francisco, CA); UCSF Helen Diller Family Comprehensive Cancer Center (San Francisco, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  50. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

    NCT06627647

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (San Francisco, CA); Research Site (Walnut Creek, CA)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    2 sites within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lung Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.